Adia Med Inc ADIA
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 311.01% | 145.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 311.01% | 145.54% | |||
| Cost of Revenue | 121.26% | 90.12% | |||
| Gross Profit | 986.49% | 372.34% | |||
| SG&A Expenses | 89.21% | 71.57% | |||
| Depreciation & Amortization | 27.27% | 62.50% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 84.75% | 80.03% | |||
| Operating Income | 144.43% | -37.47% | |||
| Income Before Tax | 132.58% | -39.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 132.58% | -39.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 132.58% | -39.85% | |||
| EBIT | 144.43% | -37.47% | |||
| EBITDA | 153.24% | -37.22% | |||
| EPS Basic | 128.57% | -41.67% | |||
| Normalized Basic EPS | 133.33% | -37.50% | |||
| EPS Diluted | 121.43% | -41.67% | |||
| Normalized Diluted EPS | 122.22% | -37.50% | |||
| Average Basic Shares Outstanding | 5.31% | -1.56% | |||
| Average Diluted Shares Outstanding | 80.06% | -1.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||